BioMarin Announces That FDA Has Advised it Will Not Take Action on the Kyndrisaâ„¢ (drisapersen) New Drug Application by the PDUFA Date

Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.